SUCROSOMIAL TECHNOLOGY

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds.

CETYLATED FATTY ACIDS

A patented solution designed to enhance joint and muscle mobility, known for its exceptional skin penetration and rapid absorption.

PRODUCTS

PharmaNutra products are designed to provide a safe and effective response to health and well-being requirements at any stage of life.
R&D

We are committed to advancing nutraceutical science by developing effective, high-quality supplements and medical devices.

In our laboratories, we use cutting-edge research models to drive innovation, blending solid scientific methods with a forward-thinking approach to technology and patents. PharmaNutra's research focuses on key health areas, especially addressing nutritional deficiencies in minerals and vitamins, supporting muscle and joint health and enhancing functional and sports nutrition.

MORE
THERAPEUTIC AREAS

Our scientific research

NEWS

Inform, innovate, inspire: putting health first

Stay updated with the latest from PharmaNutra: scientific insights, events, groundbreaking products and updates tailored to support your professional practice.
Raw materials

Alesco at SSW 2015 in Las Vegas

Read more
News & Events

Pfizer invests in PharmaNutra’s Sucrosomial® Technology

Read more
Iron deficiency

Iron deficiency anaemia: a frequent complication in chronic kidney disease (CKD)

Read more
News & Events

The Italian Spirit of Le Mans. Back to 24h: the Cetilar Villorba Corse film preview

Read more
Raw materials

ATURA: plant protein concentrates

Read more
Raw materials

Alesco obtains distribution rights for Bioenergy Ribose®

Read more
Iron deficiency

The success of the 5th International Multidisciplinary Course on Iron Anemia

Read more
News & Events

The new Dallara P217 of the Cetilar Villorba Corse team has been unveiled

Read more
News & Events

PharmaNutra among the exhibiting companies of CPhI Japan 2019

Read more
News & Events

Cetilar Racing nears top-10 finish at the 24 Hours of Le Mans

Read more
News & Events

The Sinergie-SIMA 2020 Conference: PharmaNutra a Main Partner

Read more
Muscles and joints

Cetilar® – Low Back Pain

Read more
Raw materials

Alesco-PharmaNutra Merger: from July 2024, Alesco will become a business division of the Group

Read more
Muscles and joints

Cetilar® and tendinopathies

Read more
Raw materials

New markets on the horizon

Read more